Search results
Results from the WOW.Com Content Network
In 2012 ivacaftor was designated as an orphan drug, identifying cystic fibrosis as affecting fewer than 200,000 people in the United States.On 31 January 2012, Vertex gained FDA approval [22] of the first drug, Kalydeco, [23] to treat the underlying cause of cystic fibrosis rather than the symptoms, in patients 6 years or older who have the G551D gene mutation.
Reshma Kewalramani, is the president and chief executive officer of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts, as of April 1, 2020. [ 1 ] [ 2 ] [ 3 ] She is the first female CEO of a large US biotech company. [ 2 ]
Jeffrey Leiden is an American physician, scientist and businessman who is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. [1] He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020. [2] [3]
Vertex Pharmaceuticals sold the royalty it receives on hepatitis C drug Incivo to its longtime partner Janssen Pharmaceutical, a subsidiary of Johnson & Johnson , for $152 million, the company ...
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us
[3] [4] She then joined Vertex Pharmaceuticals as the chief scientific officer before becoming the senior VP of research and development and ultimately serving as the president of Vertex Pharmaceuticals from 2000 to 2005. During her tenure, the drugs Avonex, Tysabri, and Telaprevir were developed. [5] [6]
Science & Tech. Shopping. Sports